FI60560C - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara substituerade pyridylguanidiner samt deras tautomera former - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt anvaendbara substituerade pyridylguanidiner samt deras tautomera former Download PDF

Info

Publication number
FI60560C
FI60560C FI753520A FI753520A FI60560C FI 60560 C FI60560 C FI 60560C FI 753520 A FI753520 A FI 753520A FI 753520 A FI753520 A FI 753520A FI 60560 C FI60560 C FI 60560C
Authority
FI
Finland
Prior art keywords
group
formula
substituted
tert
pyridyl
Prior art date
Application number
FI753520A
Other languages
English (en)
Finnish (fi)
Other versions
FI753520A (fr
FI60560B (fi
Inventor
Hans Joergen Petersen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of FI753520A publication Critical patent/FI753520A/fi
Publication of FI60560B publication Critical patent/FI60560B/fi
Application granted granted Critical
Publication of FI60560C publication Critical patent/FI60560C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
FI753520A 1974-12-20 1975-12-12 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara substituerade pyridylguanidiner samt deras tautomera former FI60560C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB55209/74A GB1489879A (en) 1974-12-20 1974-12-20 N'-cyano-n'-3-pyridylguanidines
GB5520974 1974-12-20

Publications (3)

Publication Number Publication Date
FI753520A FI753520A (fr) 1976-06-21
FI60560B FI60560B (fi) 1981-10-30
FI60560C true FI60560C (fi) 1982-02-10

Family

ID=10473276

Family Applications (1)

Application Number Title Priority Date Filing Date
FI753520A FI60560C (fi) 1974-12-20 1975-12-12 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara substituerade pyridylguanidiner samt deras tautomera former

Country Status (22)

Country Link
US (2) US4057636A (fr)
JP (1) JPS6028819B2 (fr)
AT (1) AT346357B (fr)
BE (1) BE836885A (fr)
CA (1) CA1067083A (fr)
CH (1) CH618429A5 (fr)
DD (1) DD122529A5 (fr)
DE (2) DE2557438A1 (fr)
DK (1) DK145341C (fr)
ES (1) ES443725A1 (fr)
FI (1) FI60560C (fr)
FR (1) FR2294703A1 (fr)
GB (1) GB1489879A (fr)
IE (1) IE42141B1 (fr)
IT (1) IT1062213B (fr)
LU (1) LU74071A1 (fr)
NL (1) NL184109C (fr)
PH (1) PH12506A (fr)
SE (1) SE424637B (fr)
SU (1) SU683615A3 (fr)
YU (1) YU39754B (fr)
ZA (1) ZA757481B (fr)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5562066A (en) * 1978-11-03 1980-05-10 Toshihiko Okamoto N-(2-substituted-4-pyridyl)-urea and thio urea, their preparation and plant growth regulator
US4490533A (en) * 1980-12-22 1984-12-25 Merck & Co., Inc. Aminoalkyl pyridine derivatives
IE52935B1 (en) * 1981-04-15 1988-04-13 Leo Pharm Prod Ltd Pharmaceutical preparation
IE54196B1 (en) * 1981-09-10 1989-07-19 Leo Pharm Prod Ltd Chemical compounds
DK58983D0 (da) * 1983-02-11 1983-02-11 Leo Pharm Prod Ltd Farmaceutisk praeparat
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
US4617311A (en) * 1985-05-17 1986-10-14 Eli Lilly And Company Antiasthmatic method
EP0302595B1 (fr) * 1987-07-07 1994-02-02 Beecham Group Plc Pinacidil pour le traitement de l'hypertension pulmonaire ou de l'insuffisance ventriculaire droite
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation
GB8801318D0 (en) * 1988-01-21 1988-02-17 Leo Pharm Prod Ltd Pharmaceutical preparations
US5244664A (en) * 1988-01-21 1993-09-14 Leo Pharmaceutical Products Ltd. Topical preparation for treatment of alopecia
WO1989010757A1 (fr) * 1988-05-10 1989-11-16 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemis Nouvelle preparation ophtalmique pour le traitement de glaucomes
US5011837A (en) * 1988-08-09 1991-04-30 E. R. Squibb & Sons, Inc. Aryl cyanoguanidines: potassium channel activators and method of making same
NZ229828A (en) * 1988-08-09 1992-03-26 Squibb & Sons Inc Aryl cyanoguanidine derivatives and pharmaceutical compositions
US5278169A (en) * 1988-08-09 1994-01-11 E. R. Squibb & Sons, Inc. Method of treating or prevention of fibrillation of the heart
JP2884412B2 (ja) * 1988-10-21 1999-04-19 日本バイエルアグロケム株式会社 殺虫性シアノ化合物
EP0381504A3 (fr) * 1989-02-03 1991-09-04 Eli Lilly And Company Dérivés de guanidine
US5264445A (en) * 1989-02-03 1993-11-23 Eli Lilly And Company (-)-N"-cyano-N-3-pyridyl-N'-1,2,2-trimethylpropylguanidine
EP0407346A3 (en) * 1989-07-07 1991-10-02 Ciba-Geigy Ag Aminopyridines
US5006523A (en) * 1989-10-26 1991-04-09 E. R. Squibb & Sons, Inc. Antiarrhythmic agents: aryl cyanoguanidine potassium channel blockers
US5217982A (en) * 1990-09-25 1993-06-08 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive properties
US5371086A (en) * 1991-03-15 1994-12-06 The Green Cross Corporation Aminopyridine compounds
JPH05294935A (ja) * 1991-03-15 1993-11-09 Green Cross Corp:The アミノピリジン系化合物
FR2677019B1 (fr) * 1991-05-27 1994-11-25 Pf Medicament Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique.
US5593993A (en) * 1991-08-02 1997-01-14 Medivir Ab Method for inhibition of HIV related viruses
IL102548A (en) * 1991-08-02 1998-08-16 Medivir Ab Use of painting derivatives in the preparation of drugs for VIH inhibition and treatment of SDIA and new compounds
KR940703666A (ko) * 1991-12-23 1994-12-12 로렌스 티. 웰츠 발기 부전증 치료에 효능있는 약제(a potent drug for treatment of erectile dysfunction)
US5262419A (en) * 1992-06-11 1993-11-16 E. R. Squibb & Sons, Inc. Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
AU4530693A (en) * 1992-08-13 1994-03-15 Upjohn Company, The Cyanoguanidines as potassium channel blockers
GB9219472D0 (en) * 1992-09-15 1992-10-28 Leo Pharm Prod Ltd Chemical compounds
JPH06228100A (ja) * 1992-12-07 1994-08-16 Green Cross Corp:The 光学活性アミノピリジン誘導体およびその用途
ATE176905T1 (de) * 1993-06-11 1999-03-15 Upjohn Co Pyrimidine-cyanoguanidine als kaliumkanalblocker
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
US5633374A (en) * 1993-11-26 1997-05-27 The Upjohn Company Pyrimidine, cyanoguanidines as K-channel blockers
WO1995020579A1 (fr) * 1994-01-28 1995-08-03 Pharmacia & Upjohn Company Cyanoguanidines utilisees comme agents bloquants des canaux k
US5525742A (en) * 1994-06-10 1996-06-11 The Upjohn Company Azidophenylcyanoguanidines as photoaffinity probes
US5856449A (en) * 1994-11-17 1999-01-05 Pharmacia & Upjohn Company Protein affecting KATP channels
WO1998006399A1 (fr) * 1996-08-15 1998-02-19 Smithkline Beecham Corporation Antagonistes du recepteur d'il-8
US5972894A (en) * 1997-08-07 1999-10-26 Cytran, Inc. Peptides having potassium channel opener activity
US6013668A (en) * 1997-08-13 2000-01-11 Bristol-Myers Squibb Company Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl) amino]methyl]amino]benzonitrile
US6458835B2 (en) 1997-08-13 2002-10-01 Bristol-Myers Squibb Company Method of inhibiting or treating chemotherapy-induced hair loss
AU9211098A (en) * 1997-09-03 1999-03-22 American Home Products Corporation Thiourea for increasing hdl-cholesterol levels, which are useful as anti-atherosclerotic agents
US6255323B1 (en) 1999-04-09 2001-07-03 Shionogi Bioresearch Corp. Cyanoguanidine compounds
GB9908410D0 (en) 1999-04-13 1999-06-09 Pfizer Ltd Pyridines
AU4841700A (en) 1999-05-12 2000-11-21 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
US6645968B2 (en) 1999-08-03 2003-11-11 Abbott Laboratories Potassium channel openers
WO2004037789A2 (fr) * 2002-10-24 2004-05-06 Merck Patent Gmbh Derives de methylene uree
WO2007022964A2 (fr) * 2005-08-24 2007-03-01 Abbott Gmbh & Co. Kg Composes guanidine a substitution hetaryl et utilisation en tant que partenaires de liaison pour des recepteurs de 5-ht5
US20070250567A1 (en) * 2006-04-20 2007-10-25 Graham Philip R System and method for controlling a telepresence system
US20110009446A1 (en) * 2008-01-11 2011-01-13 Nektar Therapeutics Oligomer-guanidine class conjugates
WO2012077108A1 (fr) * 2010-12-09 2012-06-14 Radikal Therapeutics Inc. Dérivés de nitroxyde multifonctionnels et leurs utilisations
WO2021044413A1 (fr) * 2019-09-03 2021-03-11 Salzman Group Ltd. Agents d'ouverture des canaux potassiques régulés par l'atp comprenant de la guanidine et leurs utilisations
WO2023176554A1 (fr) * 2022-03-14 2023-09-21 国立大学法人東北大学 Agent améliorant la fonction cognitive

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3036083A (en) * 1959-05-15 1962-05-22 Ciba Geigy Corp Certain 2-pyridyl lower alkyl guanidines
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines

Also Published As

Publication number Publication date
CH618429A5 (fr) 1980-07-31
ATA936075A (de) 1978-03-15
ES443725A1 (es) 1977-04-16
AU8712775A (en) 1977-06-09
ZA757481B (en) 1977-01-26
IT1062213B (it) 1983-09-20
FI753520A (fr) 1976-06-21
NL184109B (nl) 1988-11-16
SE7514153L (sv) 1976-06-21
US4057636A (en) 1977-11-08
DK145341B (da) 1982-11-01
IE42141L (en) 1976-06-20
YU316275A (en) 1982-02-28
NL7514852A (nl) 1976-06-22
DD122529A5 (fr) 1976-10-12
DK145341C (da) 1983-03-28
BE836885A (fr) 1976-06-21
DE2557438A1 (de) 1976-06-24
GB1489879A (en) 1977-10-26
FR2294703A1 (fr) 1976-07-16
SU683615A3 (ru) 1979-08-30
CA1067083A (fr) 1979-11-27
IE42141B1 (en) 1980-06-04
DK572975A (da) 1976-06-21
LU74071A1 (fr) 1976-11-11
YU39754B (en) 1985-04-30
AT346357B (de) 1978-11-10
FI60560B (fi) 1981-10-30
PH12506A (en) 1979-04-18
JPS5186474A (fr) 1976-07-29
NL184109C (nl) 1989-04-17
DE2560633C2 (fr) 1988-09-08
SE424637B (sv) 1982-08-02
USRE31244E (en) 1983-05-17
JPS6028819B2 (ja) 1985-07-06
FR2294703B1 (fr) 1980-06-27
DE2557438C2 (fr) 1989-01-05

Similar Documents

Publication Publication Date Title
FI60560C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara substituerade pyridylguanidiner samt deras tautomera former
Petersen et al. Synthesis and hypotensive activity of N-alkyl-N''-cyano-N'-pyridylguanidines
EP0100200B1 (fr) Amino-4 diméthoxy-6,7 quinoléines substituées en position 2
CA2176012C (fr) Nouveaux carbamates de phenylalkylaminoalcool et leur procede d'elaboration
CH644105A5 (fr) Acides et esters 4-amino-3-quinoleinecarboxyliques, utiles notamment comme agent antisecretoires et anti-ulcere.
CA1086735A (fr) Piperidino-quinazolines
HUE032761T2 (en) Process for the preparation of piperazinyl and diazepanylbenzamide derivatives
EP0018151B1 (fr) 6-Aryl (substitué)-7-aminopyrido(2,3-d)pyrimidine, ses dérivés et ses sels, compositions pharmaceutiques les contenant et procédés pour leur préparation
EP0325397A1 (fr) Dérivés de diurée utiles comme médicaments et procédé de leur préparation
FR2556343A1 (fr) Nouveaux derives d'aminoguanidine, procede pour leur preparation et medicaments les contenant
NZ743377A (en) Alkyl dihydroquinoline sulfonamide compounds
JPH05247069A (ja) アミノアルカンホスフィン酸およびその塩
SK28598A3 (en) Optically active phenyl pyrimidine derivative as analgesic agent
WO2006120348A1 (fr) Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP3103271B2 (ja) 新規なベンゾスピロアルケン化合物、それらの製造法 及びそれら化合物を含有する製剤組成物
US20040039045A1 (en) (2-azabicyclo[2.2.1]hept-7yl) methanol derivatives as nicotinic acetylcholine receptor agonists
HU182645B (en) Process for preparing n-cyano-n'-2-//4-methyl-5-imidazolyl/-methyl-thio/-ethyl-n''-alkinyl-guanidine
GB1598628A (en) Guanidine derivatives
RU2298010C2 (ru) Производные дигидроимидазо[5,1-а]- бета-карболина, способ их получения и фармацевтическая композиция
US7906547B2 (en) Azabicylic compounds, a process for their preparation and pharmaceutical compositions containing them
JP2798628B2 (ja) 癲癇治療用の５−アミノカルボニル−５Ｈ−ジベンゾ［ａ，ｄ］シクロヘプテン−５，１０−イミン
KR800000411B1 (ko) 퀴나졸린 유도체의 제조방법
US4229462A (en) Method for controlling hypertension and compositions
JPS6037097B2 (ja) グアニジン誘導体およびそれを含有する血圧降下剤組成物
CA1207768A (fr) Carboxamidoguanidines, leur procede d'obtention et les compositions pharmaceutiques en renfermant

Legal Events

Date Code Title Description
MA Patent expired
MA Patent expired

Owner name: LEO PHARMACEUTICAL PRODUCTS LTD A/S (LOEVENS KEMIS